2m 2m 2m 2m 2m 2m 2m
ABVC BIOPHARMA (ABVC)
NASDAQ
$1.01+$0.004 (+0.40%)
Price as of Oct 02, 2026 7:37 PM EDT- $27.2MMarket Cap
- -66.33%1-Year Change
- BiotechnologyIndustry
ABVC BIOPHARMA (ABVC)
$1.01+$0.004 (+0.40%)
ABVC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.01 | ||
Change | -$0.01 (-0.98%) | ||
Open | $1.03 | ||
High | $1.08 | ||
Low | $1.00 | ||
Previous Close | $1.02 | ||
Volume | 98,683 | ||
30-Day Average Volume | 138,245 | ||
1-Week Change | -10.62% | ||
1-Month Change | 16.83% | ||
1-Year Change | -66.33% | ||
3-Year Change | 9.78% | ||
5-Year Change | -95.55% | ||
Fundamentals | |||
Shares Outstanding | 26.7M | ||
Total Assets | $19.4M | ||
Market Cap | $27.2M | ||
Enterprise Value | $27.5M | ||
Period: QTR TTM FY | |||
Revenue | -$36.00 | ||
Net Income | -$736,934.00 | ||
Free Cash Flow | -$244,413.00 | ||
EBIT | -$736,934.00 | ||
EBITDA | -$730,418.00 | ||
Net Working Capital | -$5.3M | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | -38 | ||
Enterprise Value/Revenue | -765,153 | ||
P/B | 3 | ||
P/E | -34 | ||
PEG | -1 | ||
Price/Free Cash Flow | -111 | ||
Price/Operating Cash Flow | -111 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 07/25/2023 | ||
Earnings & Revenue